-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on WAVE Life Sciences, Raises Price Target to $30

Benzinga·12/19/2025 16:21:05
语音播报
HC Wainwright & Co. analyst Andrew S. Fein maintains WAVE Life Sciences (NASDAQ:WVE) with a Buy and raises the price target from $22 to $30.